An Initial Evaluation of AN8025 in Solid Tumors

Clinical trial NCT07639047 · RECRUITING

Trial details

NCT number: NCT07639047
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor (Phase 1)

Start date: 2025-11-01
Primary completion: 2027-07-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.